Institut des Sciences Moléculaires d'Orsay (ISMO), Université Paris-Saclay, CNRS UMR 8214, 91405 Orsay, France.
Centre de Nanosciences et de Nanotechnologies (C2N), Université Paris-Saclay, CNRS UMR 9001, 91120 Palaiseau, France.
ACS Appl Mater Interfaces. 2024 Mar 20;16(11):14296-14307. doi: 10.1021/acsami.3c18958. Epub 2024 Mar 7.
Porous iron(III) carboxylate metal-organic frameworks (MIL-100; MIL stands for Material of Institute Lavoisier) of submicronic size (nanoMOFs) have attracted a growing interest in the field of drug delivery due to their high drug payloads, excellent entrapment efficiencies, biodegradable character, and poor toxicity. However, only a few studies have dealt with the nanoMOF degradation mechanism, which is key to their biological applications. Complementary methods have been used here to investigate the degradation mechanism of Fe-based nanoMOFs under neutral or acidic conditions and in the presence of albumin. High-resolution STEM-HAADF coupled with energy-dispersive X-ray spectroscopy enabled the monitoring of the crystalline organization and elemental distribution during degradation. NanoMOFs were also deposited onto silicon substrates by dip-coating, forming stable thin films of high optical quality. The mean film thickness and structural changes were further monitored by IR ellipsometry, approaching the "sink conditions" occurring . This approach is essential for the successful design of biocompatible nano-vectors under extreme diluted conditions. It was revealed that while the presence of a protein coating layer did not impede the degradation process, the pH of the medium in contact with the nanoMOFs played a major role. The degradation of nanoMOFs occurred to a larger extent under neutral conditions, rapidly and homogeneously within the crystalline matrices, and was associated with the departure of their constitutive organic ligand. Remarkably, the nanoMOFs' particles maintained their global morphology during degradation.
亚微米尺寸的多孔铁(III)羧酸金属有机骨架(MIL-100;MIL 代表 Material of Institute Lavoisier)因其高载药量、优异的包封效率、可生物降解性和低毒性,在药物传递领域引起了越来越多的关注。然而,只有少数研究涉及纳米 MOF 的降解机制,这是其生物应用的关键。在这里,我们使用了互补的方法来研究中性或酸性条件下以及白蛋白存在下 Fe 基纳米 MOF 的降解机制。高分辨率 STEM-HAADF 与能谱分析相结合,使我们能够在降解过程中监测晶体组织和元素分布。纳米 MOF 也通过浸涂沉积在硅衬底上,形成具有高光学质量的稳定薄膜。通过红外椭圆光度法进一步监测平均膜厚和结构变化,接近发生的“汇条件”。这种方法对于在极端稀释条件下成功设计生物相容性纳米载体至关重要。结果表明,虽然蛋白质涂层的存在并没有阻碍降解过程,但与纳米 MOF 接触的介质的 pH 值起着主要作用。在中性条件下,纳米 MOF 的降解程度更大,在晶体基质中迅速且均匀地发生,并且与它们组成的有机配体的离去有关。值得注意的是,纳米 MOF 的颗粒在降解过程中保持其整体形态。